Again, a Danish biomanufacturing company, announced the acquisition of Genomatica to integrate its modular fermentation technology with Geno’s advanced artificial intelligence platform for biomolecule design. This strategic move unites Again’s on-site microbial bioreactors that convert industrial CO2 emissions into valuable chemical feedstocks with Geno’s expertise in engineering microorganisms through AI-driven processes.
By co-locating bioreactors directly with industrial CO2 emitters, Again transforms waste gas into intermediates such as acetate and acetic acid using specialized microbes that fix carbon dioxide. These compounds serve as renewable raw materials for manufacturing adhesives, solvents, plastics, textiles, and cosmetics. The approach enables commercial-scale CO2 producers to become hubs for recycling carbon emissions, reducing reliance on fossil-derived chemicals.
Geno specializes in engineering microorganisms, primarily Escherichia coli strains, to ferment plant sugars into bio-based chemicals traditionally derived from fossil fuels. Its portfolio includes renewable ingredients for spandex, cosmetics, nylon, and specialty fragrance building blocks. Geno supports commercial scalability by licensing its biotechnology processes to major manufacturers rather than solely operating its own plants.
The acquisition grants Again access to Geno’s comprehensive AI-powered biotech platform and patent portfolio, which contains extensive data from experimental results and development projects. This enhances precision in discovering new biochemical pathways and accelerates bringing innovative products from concept to market.